Redirecting T cells to glypican-3 with 28.41BB.ζ and 28.ζ-41BBL CARs for hepatocellular carcinoma treatment

{{article.zuoZheEn}}

PDF(1376 KB)
PDF(1376 KB)
Protein Cell ›› 2018, Vol. 9 ›› Issue (7) : 664-669. DOI: 10.1007/s13238-017-0489-0
LETTER

Redirecting T cells to glypican-3 with 28.41BB.ζ and 28.ζ-41BBL CARs for hepatocellular carcinoma treatment

  • {{article.zuoZheEn}}
Author information +
History +

Highlights

{{article.highlightEn}}

Abstract

{{article.abstractEn}}

Author summary

{{article.authorSummayEn}}

Keywords

Cite this article

EndNote

Ris (Procite)

Bibtex

Download citation ▾
{{article.zuoZheEn_L}}. {{article.titleEn}}. Protein Cell, 2018, 9(7): 664‒669 https://doi.org/10.1007/s13238-017-0489-0

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

RIGHTS & PERMISSIONS

{{article.copyright.year}} {{article.copyright.holder}}
PDF(1376 KB)

Accesses

Citations

Detail
Sections
Recommended

/

〈 〉